Bagsværd, Denmark, 3 April 2017 - In continuation of the company's announcements dated 28 October 2016 and 2 February 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 March 2017 owned 63,031,862 of its own B shares of DKK 0.20, corresponding to a total nominal value of *DKK 2,845,332,705 or 2.5% of the total share capital.
In the first quarter of 2017 a total of 17,934,545 B shares were repurchased, and 569,935 B shares were disposed to employees in connection with employee incentive programmes.
*Amendment: DKK 2,845,332,705 should have been: DKK 12,606,372Further information
Media: | ||
Anne Margrethe Hauge | +45 4442 3450 | amhg@novonordisk.com |
Ken Inchausti (US) | +1 609 786 8316 | kiau@novonordisk.com |
Investors: | ||
Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
Hanna Ögren | +45 3079 8519 | haoe@novonordisk.com |
Anders Mikkelsen | +45 3079 4461 | armk@novonordisk.com |
Kasper Veje (US) | +1 609 235 8567 | kpvj@novonordisk.com |
Company announcement No 27/2017